12/4
05:23 pm
slno
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
Low
Report
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
12/3
04:17 pm
slno
Soleno Therapeutics Announces the Passing of Board Member William G. Harris [Yahoo! Finance]
Medium
Report
Soleno Therapeutics Announces the Passing of Board Member William G. Harris [Yahoo! Finance]
12/3
04:05 pm
slno
Soleno Therapeutics Announces the Passing of Board Member William G. Harris
Medium
Report
Soleno Therapeutics Announces the Passing of Board Member William G. Harris
12/1
05:48 pm
slno
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
Low
Report
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
11/30
09:33 pm
slno
Soleno Therapeutics (SLNO): Does Current Valuation Signal Opportunity or Caution for Investors? [Yahoo! Finance]
Low
Report
Soleno Therapeutics (SLNO): Does Current Valuation Signal Opportunity or Caution for Investors? [Yahoo! Finance]
11/25
08:51 am
slno
Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns [Yahoo! Finance]
Low
Report
Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns [Yahoo! Finance]
11/24
12:03 pm
slno
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
Low
Report
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
11/24
08:00 am
slno
Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
11/20
10:00 am
slno
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
11/20
06:03 am
slno
Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
11/18
09:00 am
slno
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
Medium
Report
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
11/16
05:05 pm
slno
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
Medium
Report
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
11/16
08:30 am
slno
Need To Know: Analysts Are Much More Bullish On Soleno Therapeutics, Inc. (NASDAQ:SLNO) [Yahoo! Finance]
Medium
Report
Need To Know: Analysts Are Much More Bullish On Soleno Therapeutics, Inc. (NASDAQ:SLNO) [Yahoo! Finance]
11/14
10:05 am
slno
SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - RGRD Law
Low
Report
SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - RGRD Law
11/13
12:17 pm
slno
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% – Hagens Berman
Low
Report
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% – Hagens Berman
11/12
10:56 am
slno
Soleno Therapeutics, Inc. Investigated by the Portnoy Law Firm
Low
Report
Soleno Therapeutics, Inc. Investigated by the Portnoy Law Firm
11/11
01:05 pm
slno
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
Low
Report
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
11/11
07:00 am
slno
SLNO INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Soleno Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
Low
Report
SLNO INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Soleno Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
11/11
07:00 am
slno
Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement
Low
Report
Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement
11/10
02:45 pm
slno
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
Low
Report
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
11/7
07:48 pm
slno
Soleno Therapeutics (SLNO) Ends 26% Lower After Q3 Earnings [Yahoo! Finance]
Medium
Report
Soleno Therapeutics (SLNO) Ends 26% Lower After Q3 Earnings [Yahoo! Finance]
11/7
07:30 pm
slno
SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
Low
Report
SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
11/7
10:04 am
slno
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKATÔ XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman
Medium
Report
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKATÔ XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman
11/6
02:38 pm
slno
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman
Low
Report
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman
11/6
05:38 am
slno
Soleno Therapeutics (SLNO): Losses Accelerate 43.6% Annually, Challenging Bullish Profitability Narrative [Yahoo! Finance]
Medium
Report
Soleno Therapeutics (SLNO): Losses Accelerate 43.6% Annually, Challenging Bullish Profitability Narrative [Yahoo! Finance]